| Literature DB >> 33594378 |
Andrew D Redd1,2, Alessandra Nardin3, Hassen Kared3, Evan M Bloch4, Andrew Pekosz5, Oliver Laeyendecker1,2, Brian Abel3, Michael Fehlings3, Thomas C Quinn1,2, Aaron Ar Tobian4.
Abstract
This study examined whether CD8+ T-cell responses from COVID-19 convalescent individuals(n=30) potentially maintain recognition of the major SARS-CoV-2 variants. Out of 45 mutations assessed, only one from the B.1.351 Spike overlapped with a low-prevalence CD8+ epitope, suggesting that virtually all anti-SARS-CoV-2 CD8+ T-cell responses should recognize these newly described variants.Entities:
Year: 2021 PMID: 33594378 PMCID: PMC7885937 DOI: 10.1101/2021.02.11.21251585
Source DB: PubMed Journal: medRxiv